(unless contra-indicated for individuals with confirmed chronic kidney disease), elevated urine albumin, and elevated blood pressure in alignment with evidence-based guidelines. (iv) Providing such individuals, as appropriate, with planned starts of renal replacement therapy through the receipt by such individuals of preemptive kidney transplants, the initiation of home dialysis, the initiation of outpatient in-center hemodialysis through arteriovenuous fistula or arteriovenous graft, or supportive care. (C) Flexibility in measure specification For purposes of subparagraph (A), the Secretary may specify measures that the Secretary develops for purposes of such subparagraph or that the Secretary did not develop for such purposes. (4) Application of early detection and treatment demonstration program provisions The Secretary shall, under this subsection, apply the provisions of paragraphs (4), (5), (6), (7), and (10) of subsection (a) to the advanced CKD demonstration program, advanced CKD practitioners, advanced CKD services, and individuals described in paragraph (1) to the same extent that such provisions apply under subsection (a) to the CKD early detection and treatment demonstration program, CKD–EDT practitioners, CKD–EDT services, and enrolled CKD–EDT individuals, respectively. (5) Definitions For purposes of this section, the following definitions apply: (A) Advanced CKD practitioner Subject to paragraph (6), the term advanced CKD practitioner means, with respect to an individual described in paragraph (1), a nephrologist who— (i) participates in the Medicare program under this title